Richard Ransohoff
Founder of Abata Therapeutics
Richard Ransohoff
Founder of Abata Therapeutics
Greater Boston
Overview
Work Experience
Venture Partner
2019 - Current
Entrepreneur In Residence
2018 - 2019
Co-founder and Chief Medical Officer
2021
VP
2014 - 2017
My responsibility at Biogen as VP, and Research/Early Development Unit Head for Neuroimmunology & MS/Pain/Acute Neurology ([NIPAN]; 2014-2017) entailed leading a group of >45 scientists and clinicians in finding and prosecuting neuroinflammatory targets for treatment of neurological disease and pain, and bringing those relevant for acute neurology indications through phase II proof of concept (PoC). During this time, I led the transformation of the neuroinflammation portfolio, successfully bringing 5 compounds (internally developed and externally identified) into the clinic as well as directing activities in blood-brain barrier (BBB) function, progressive multifocal leukoencephalopathy (PML) risk mitigation and novel screening technologies for glial targets, in addition to basic neuroinflammation biology.
Member Of Scientific Staff
1989 - 2014
Neurologist
1984 - 2014
Staff Neurologist, Mellen Center for MS Treatment and Research, Neurological Institute, Cleveland Clinic. Named in "Best Doctors" 1996-2014"